Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL-112) LEUKEMIA LYMPHOMA
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles Eur J Pharm Biopharm
SpadaHC: a database to improve the classification of variants in hereditary cancer genes in the Spanish population DATABASE-OXFORD
Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT Blood
IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development Nat Commun
Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma Cell Death Discov
Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement Front Immunol
Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma NAT COMMUN